CLINICAL_TRIALS
trial_result
· 2021-05-27
Clinical Trial Update: Evaluation of the Onset of Action in Highly Active MS (MAGNIFY) [Phase 4]
Summary
Phase 4 clinical trial update evaluating onset of action in highly active multiple sclerosis; completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2021-05-27